Differentially charged isoforms of apolipoprotein e from human blood are potential biomarkers of Alzheimer's disease

Alzheimer's Research and Therapy

Volumn 6, Issue 4, 2014, Pages

  Alzate, Oscar ^a,b,c   Osorio, Cristina ^a   Dekroon, Robert M ^a   Corcimaru, Ana ^a   Gunawardena, Harsha P ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b UNIVERSIDAD PONTIFICIA BOLIVARIANA   (Colombia)

^c TEXAS A M COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; BIOLOGICAL MARKER; ISOPROTEIN;

ADULT; ALZHEIMER DISEASE; ARTICLE; BLOOD ANALYSIS; BRAIN TISSUE; CEREBROSPINAL FLUID ANALYSIS; CONTROLLED STUDY; FEMALE; GENOTYPE; HUMAN; ISOELECTRIC POINT; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEOMICS; WESTERN BLOTTING;

EID: 84904077809     PISSN: None     EISSN: 17589193     Source Type: Journal    
DOI: 10.1186/alzrt273     Document Type: Article

References (40)

1. Alzheimer's disease facts and figures. Thies W, Bleiler L, Alzheimers Dement 2011 2011 208 244
2. Systematic meta-analyses of Alzheimer's disease genetic association studies: the AlzGene database. Bertram L, McQueen MB, Mullin K, Blacker D, Tanzi RE, Nat Genet 2007 39 17 23 10.1038/ng1934 17192785
3. Apolipoprotein E alleles as risk factors in Alzheimer's disease. Roses AD, Annu Rev Med 1996 47 387 400 10.1146/annurev.med.47.1.387 8712790
4. Apolipoprotein E, a gene with complex biological interactions in the aging brain. Roses AD, Neurobiol Dis 1997 4 170 185 10.1006/nbdi.1997.0161 9361294
5. Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer's disease. Strittmatter WJ, Saunders AM, Schmechel D, Pericak-Vance M, Enghild J, Salvesen GS, Roses AD, Proc Natl Acad Sci U S A 1993 90 1977 1981 10.1073/pnas.90.5.1977 8446617
6. Binding of human apolipoprotein E to synthetic amyloid beta peptide: isoform-specific effects and implications for late-onset Alzheimer's disease. Strittmatter WJ, Weisgraber KH, Huang DY, Dong LM, Salvesen GS, Pericak-Vance M, Schmechel D, Saunders AM, Goldgaber D, Roses AD, Proc Natl Acad Sci U S A 1993 90 8098 8102 10.1073/pnas.90.17.8098 8367470
7. Alzheimer's disease risk genes and the age-at-onset phenotype. Thambisetty M, An Y, Tanaka T, Neurobiol Aging 2013 34 2696. e1-5 23870418
8. Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Mahley RW, Science 1988 240 622 630 10.1126/science.3283935 3283935
9. Apolipoprotein E4: a causative factor and therapeutic target in neuropathology, including Alzheimer's disease. Mahley RW, Weisgraber KH, Huang Y, Proc Natl Acad Sci U S A 2006 103 5644 5651 10.1073/pnas.0600549103 16567625
10. CSF Total tau, Aβ42 and phosphorylated tau protein as biomarkers for Alzheimer's disease. Blennow K, Vanmechelen E, Hampel H, Mol Neurobiol 2001 24 87 97 10.1385/MN:24:1-3:087 11831556
11. A panel of cerebrospinal fluid potential biomarkers for the diagnosis of Alzheimer's disease. Carrette O, Demalte I, Scherl A, Yalkinoglu O, Corthals G, Burkhard P, Hochstrasser DF, Sanchez JC, Proteomics 2003 3 1486 1494 10.1002/pmic.200300470 12923774
12. Cerebrospinal fluid proteomic biomarkers for Alzheimer's disease. Finehout EJ, Franck Z, Choe LH, Relkin N, Lee KH, Ann Neurol 2007 61 120 129 10.1002/ana.21038 17167789
13. CSF studies in neuropsychiatric disorders. Raedler TJ, Wiedemann K, Neuro Endocrinol Lett 2006 27 297 305 16807525
14. Quantitative proteomic analysis of age-related changes in human cerebrospinal fluid. Zhang J, Goodlett DR, Peskind ER, Quinn JF, Zhou Y, Wang Q, Pan C, Yi E, Eng J, Aebersold RH, Montine TJ, Neurobiol Aging 2005 26 207 227 10.1016/j.neurobiolaging.2004.03.012 15582749
15. Quantitative proteomics of cerebrospinal fluid from patients with Alzheimer's disease. Zhang J, Goodlett DR, Quinn JF, Peskind E, Kaye JA, Zhou Y, Pan C, Yi E, Eng J, Wang Q, Aebersold RH, Montine TJ, J Alzheimers Dis 2005 7 125 133 discussion 173-180 15851850
16. Proteomic discovery of CSF biomarkers for Alzheimer's disease. Zhang J, Montine TJ, Ann Neurol 2007 61 497 author reply 497-498 17358005
17. Cerebrospinal fluid β-amyloid 42 and tau proteins as biomarkers of Alzheimer-type pathologic changes in the brain. Tapiola T, Alafuzoff I, Herukka SK, Parkkinen L, Hartikainen P, Soininen H, Pirttila T, Arch Neurol 2009 66 382 389 19273758
18. Blood-based protein biomarkers for diagnosis of Alzheimer's disease. Doecke JD, Laws SM, Faux NG, Wilson W, Burnham SC, Lam CP, Mondal A, Bedo J, Bush AI, Brown B, De Ruyck K, Ellis KA, Fowler C, Gupta VB, Head R, Macaulay SL, Pertile K, Rowe CC, Rembach A, Rodrigues M, Rumble R, Szoeke C, Taddei K, Taddei T, Trounson B, Ames D, Masters CL, Martins RN, Arch Neurol 2012 69 1318 1325 10.1001/archneurol.2012.1282 22801742
19. Mortalin is regulated by APOE in hippocampus of AD patients and by human APOE in TR mice. Osorio C, Sullivan PM, He DN, Mace BE, Ervin JF, Strittmatter WJ, Alzate O, Neurobiol Aging 2007 28 1853 1862 10.1016/j.neurobiolaging.2006.08.011 17050040
20. Banking tissue for neurodegenerative research. Ervin JF, Neuroproteomics Boca Raton, (FL): Frontiers in Neuroscience, Alzate O, 2010
21. Simultaneous detection of changes in protein expression and oxidative modification as a function of age and APOE genotype. DeKroon RM, Osorio C, Robinette JB, Mocanu M, Winnik WM, Alzate O, J Proteome Res 2011 10 1632 1644 10.1021/pr1009788 21210719
22. Diabetes mellitus in patients with Alzheimer's disease: clinical description and correlation with the APOE genotype in a sample population from the province of Antioquia, Colombia. Botero LE, Toro AE, Patino AJ, Salazar G, Rodriguez JC, Suarez-Escudero JC, Alarcon GA, Corcimaru A, Osorio C, Jeong JS, Alzate O, Biomedica 2012 32 239 251 23242298
23. A method for the quantitative recovery of protein in dilute solution in the presence of detergents and lipids. Wessel D, Flugge UI, Anal Biochem 1984 138 141 143 10.1016/0003-2697(84)90782-6 6731838
24. Optimizing the difference gel electrophoresis (DIGE) technology. Friedman DB, Lilley KS, Methods Mol Biol 2008 428 93 124 10.1007/978-1-59745-117-8-6 18287770
25. Assessing signal-to-noise in quantitative proteomics: multivariate statistical analysis in DIGE experiments. Friedman DB, Methods Mol Biol 2012 854 31 45 10.1007/978-1-61779-573-2-4 22311752
26. Analysis of proteins using DIGE and MALDI mass spectrometry. Winnik WM, Dekroon RM, Jeong JS, Mocanu M, Robinette JB, Osorio C, Dicheva NN, Hamlett E, Alzate O, Methods Mol Biol 2012 854 47 66 10.1007/978-1-61779-573-2-5 22311753
27. Profiling of experience-regulated proteins in the songbird auditory forebrain using quantitative proteomics. Pinaud R, Osorio C, Alzate O, Jarvis ED, Eur J Neurosci 2008 27 1409 1422 10.1111/j.1460-9568.2008.06102.x 18364021
28. Mascot Database. http://www.matrixscience.com
29. Graves DJ, Martin BL, Wang JH, Co- and Post-Translational Modifications of Proteins: Chemical Principles and Biological Effects New York: Oxford University Press 1994
30. Protein posttranslational modifications: the chemistry of proteome diversifications. Walsh CT, Garneau-Tsodikova S, Gatto GJ Jr, Agnew Chem Int Ed Engl 2005 44 7342 7372 10.1002/anie.200501023
31. Analysis of protein posttranslational modifications using DIGE-based proteomics. Dekroon RM, Robinette JB, Osorio C, Jeong JS, Hamlett E, Mocanu M, Alzate O, Methods Mol Biol 2012 854 129 143 10.1007/978-1-61779-573-2-9 22311757
32. US National Center for Biotechnology Information (NCBI). http://www.ncbi.nlm.nih.gov
33. Target-decoy search strategy for increased confidence in large-scale protein identifications by mass spectrometry. Elias JE, Gygi SP, Nat Methods 2007 4 207 214 10.1038/nmeth1019 17327847
34. Comparison of database search strategies for high precursor mass accuracy MS/MS data. Hsieh EJ, Hoopmann MR, MacLean B, MacCoss MJ, J Proteome Res 2010 9 1138 1143 10.1021/pr900816a 19938873
35. A statistical model for identifying proteins by tandem mass spectrometry. Nesvizhskii AI, Keller A, Kolker E, Aebersold R, Anal Chem 2003 75 4646 4658 10.1021/ac0341261 14632076
36. Empirical statistical model to estimate the accuracy of peptide identifications made by MS/MS and database search. Keller A, Nesvizhskii AI, Kolker E, Aebersold R, Anal Chem 2002 74 5383 5392 10.1021/ac025747h 12403597
37. Protein Information Resource (PIR). http://pir.georgetown.edu/
38. Universal Protein Resource (UniProt). http://www.uniprot.org/
39. Relative, label-free protein quantitation: spectral counting error statistics from nine replicate MudPIT samples. Cooper B, Feng J, Garrett WM, J Am Soc Mass Spectrom 2010 21 1534 1546 10.1016/j.jasms.2010.05.001 20541435
40. Mass spectrometry-based label-free quantitative proteomics. Zhu W, Smith JW, Huang CM, J Biomed Biotechnol 2010 2010 840518 19911078